Travere Therapeutics TVTX
NASDAQ TVTX
$50.08 -2.35 (-4.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Gains from Investment Securities (2013 - 2016)

Updated

Analysis

Travere Therapeutics (TVTX) Gains from Investment Securities (2013 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Travere Therapeutics 4.72 Bn 4.32 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -3,000.00
Sep 30, 2016 11,000.00
Sep 30, 2015 -400,000.00
Mar 31, 2015 107,000.00
Dec 31, 2014 -1.35 Mn
Sep 30, 2014 168,943.00
Jun 30, 2014 -18,516.00
Mar 31, 2014 537,516.00
Dec 31, 2013 9.29 Mn
Sep 30, 2013 -6.04 Mn
Mar 31, 2013 2.45 Mn
API Access

Travere Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=TVTX&period=max&api_key=YOUR_API_KEY